510(k) K250233
K250233 is an FDA 510(k) premarket notification submitted by Measure Labs, Inc. (Dba Preemptiveai, Inc.) for the device "PreemptiveAI Clinical SDK". The FDA issued a decision of Substantially Equivalent on February 13, 2026. The device falls under product code DXH (Transmitters And Receivers, Electrocardiograph, Telephone), a Class II device regulated under 21 CFR 870.2920.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 13, 2026
- Date Received
- January 27, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Transmitters And Receivers, Electrocardiograph, Telephone
- Device Class
- Class II
- Regulation Number
- 870.2920
- Review Panel
- CV
- Submission Type